GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alcon Inc (ACL) [hlAlert]

Alcon, Inc. (Alcon) is a research and development driven, global medical specialty company focused on eye care. The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye. Alcon
manages its business through two segments: Alcon United States and Alcon International. Its portfolio spans three key ophthalmic categories: pharmaceutical, surgical and consumer eye care products. In its pharmaceutical category Alcon develops, manufactures and markets a range of prescription ophthalmic pharmaceutical products. Alcon offers a range of surgical equipment, single-use and disposable products. The Company markets contact lens care products, artificial tears and ocular vitamins, in its consumer eye care products category. In July 2008, Novartis AG acquired a 25% stake in Alcon from Nestle SA.
.
( Total: 11 Current Stock Recommendations )
Alcon Inc   (11)
Hold 64% Buy 36%
Related companies
Glaxosmithkline Plc   (19)
Sell 16% Hold 63% Buy 21%
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Filter by Gains:   
  
Rating:
Hold ACL
up 87.84 %

Rating:
Hold ACL
Alcon Inc (ACL) rated Hold with price target $180 by Jefferies
Thursday,  Oct 21, 2010  9:25 AM ET

Rating:
Hold ACL
up 75.70 %

Rating:
Hold ACL
down 1.47 %
Alcon Inc (ACL) downgraded to Hold by Citigroup
Thursday,  Jan 14, 2010  8:25 AM ET

Rating:
Hold ACL
Alcon Inc (ACL) rated Neutral by UBS
Thursday,  Jan 7, 2010  9:25 AM ET

Rating:
Hold ACL

Rating:
Buy ACL
up 46.09 %

Rating:
Hold ACL

Rating:
Buy ACL
up 84.40 %
Alcon Inc (ACL) rated Buy with price target $106 by Jefferies & Co
Wednesday,  Apr 15, 2009  8:25 AM ET

Rating:
Buy ACL
up 87.84 %

Rating:
Hold ACL
down 37.28 %
Alcon Inc (ACL) downgraded to Mkt Perform by Wachovia
Monday,  Feb 23, 2009  8:25 AM ET

Rating:
Buy ACL
up 84.40 %
Alcon Inc (ACL) rated Buy with price target $96 by Jefferies & Co
Thursday,  Feb 12, 2009  8:25 AM ET

Rating:
Buy ACL
up 99.77 %
Alcon Inc (ACL) rated Buy by FTN Midwest
Wednesday,  Jan 21, 2009  9:25 AM ET

Rating:
Buy ACL
up 75.70 %
Alcon Inc (ACL) rated Outperform by BMO Capital Markets
Monday,  Jan 5, 2009  9:25 AM ET

Rating:
Buy ACL
up 100.63 %
Alcon Inc (ACL) rated Buy with price target $96 by Collins Stewart
Wednesday,  Dec 17, 2008  8:25 AM ET

Your Recent Stocks
SymbolLastChange
ACL 167.99 down  -0.20 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy